KATIE WATERS: Open Payments
NPI 1184273336 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$299 in 17 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $284 · 2025 $299
Food & beverage: $299
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $62 |
| Incyte Corporation | 2 | $38 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
| Novocure Inc. | 1 | $25 |
| BeOne Medicines USA, Inc. | 1 | $22 |
| Iovance Biotherapeutics, Inc. | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Stemline Therapeutics Inc. | 1 | $16 |
| Spectrum Pharmaceuticals Inc. | 1 | $16 |
| Eisai Inc. | 1 | $15 |
Products named: JAKAFI, LUTATHERA, Optune Gio, TEVIMBRA, Amtagvi, Fabhalta, Orserdu, ROLVEDON.
Industry payments across FL — which companies pay providers there.
